Advertisement

Geriatric Anxiety and Anxiety Disorders

  • James D. Helsley
  • Sandra K. Vanin
Chapter
  • 1.7k Downloads
Part of the Current Clinical Practice book series (CCP)
In 1965, the federal government passed the Older Americans Act (OAA) and the Administration on Aging (AoA) was created. By that act, older Americans were considered to be persons 60 years of age or older. There are many terms used to define this population of indviduals, including geriatric, senior, seasoned, and aged. This chapter uses these terms interchangeably. From a medical standpoint, age ranges vary when defining this population. As of 2004, there were 36.3 million people in the United States over the age of 65 years [1]. One in every eight Americans is an older citizen. Elderly women outnumber men by six million. The over-65 population in the United States is expected to reach 55 million by the year 2020. Approximately one third of the elderly live alone. Median income for the elderly in 2004 was $21,102 for males and $12,080 for females. One third of older Americans rely on Social Security for 90% of their income [1]. The average geriatric patient takes 3.2 drugs. Forty...

Keywords

Elderly Patient Anxiety Disorder Anxiety Symptom Generalize Anxiety Disorder Lean Body Mass 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    U.S. Department of Health and Human Services, Administration on Aging. A Profile of Older Americans. Washington, DC: DHHS, 2005.Google Scholar
  2. 2.
    Lundberg M, Larsson M, Ostlund H, Styf J. Kinesiophobia among patients with musculoskeletal pain in primary healthcare. J Rehabil Med 2006;38:37–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Reynolds C, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006;354:1130–1138.CrossRefPubMedGoogle Scholar
  4. 4.
    Smalbrugge M, Pot AM, Jongenelis L, Gundy CM, Beekman AT, Eefsting JA. The impact of depression and anxiety on well being, disability and use of health care services in nursing home patients. Int J Geriatr Psychiatry 2006;21(4):325–332.CrossRefPubMedGoogle Scholar
  5. 5.
    Janicak P, Davis J, Preskorn S, Ayd F. Principles and Practice of Psychopharmacotherapy. Baltimore, MD: Williams & Wilkins, 1993: 481–536.Google Scholar
  6. 6.
    Benet L, Mitchell J, Sheiner L. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman A, Gilman A, Rall T, Nies A, Taylor P, eds. The Pharmacologic Basis of Therapeutics. Elmsford, NY: Pergamon Press, 1990:3–48.Google Scholar
  7. 7.
    Jones J. Drugs and the elderly. In: Clinical Aspects of Aging. Baltimore, MD: Williams & Wilkins, 1989:41–60.Google Scholar
  8. 8.
    Streiner D, Cairney J, Veldhuizen S. The epidemiology of psychological problems in the elderly. Can J Psychiatry 2006; 51(3):185–191.PubMedGoogle Scholar
  9. 9.
    Beekman A, et al. Anxiety Disorders in later life: a report from the Longitudinal Aging Study, Amsterdam. Int J Geriatr Psychiatry 1998;13(10):717–726.CrossRefPubMedGoogle Scholar
  10. 10.
    Himmelfarb S, Murrell S. The prevalence and correlates of anxiety symptoms on older adults. J Psychol 1984;116:159–167.CrossRefPubMedGoogle Scholar
  11. 11.
    Ayers C, Wetherell J, Stanley M. Treating late-life anxiety. Psych Times 2006;March:17–26.Google Scholar
  12. 12.
    Blazer D. Depression. In: Abrams W, Berkow R, eds. The Merck Manual Of Geriatrics. Rahway, NJ: Merck, 1990:1014–1018.Google Scholar
  13. 13.
    Rayner A, O'Brien J, Shoenbachler B. Behavior disorders of dementia: recognition and treatment. Am Fam Physician 2006;73(4):647–652.PubMedGoogle Scholar
  14. 14.
    Wells C. Pseudodementia. Am J Psychiatry 1979;136:895.PubMedGoogle Scholar
  15. 15.
    Folstein M, et al. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189.CrossRefPubMedGoogle Scholar
  16. 16.
    Yamada K, Awadalla S. Neurologic disorders. In: Green G, Harris I, Lin G, Moylan K, eds. The Washington Manual of Medical Therapeutics. Philadelphia: Lippincott Williams & Wilkins, 2004:531–537.Google Scholar
  17. 17.
    Gaudreau J, Gagnon P, et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23(27):6712–6718.CrossRefPubMedGoogle Scholar
  18. 18.
    White S, Calver B, Newsday V, et al. Enzymes of drug metabolism during delirium. Age Ageing 2005;34(6):603–608.CrossRefPubMedGoogle Scholar
  19. 19.
    Ownby R, Hertzog C, Crocco E, Duara R. Factors related to medication adherence in memory disorder clinic patients. Aging Ment Health 2006;10(4):378–385.CrossRefPubMedGoogle Scholar
  20. 20.
    Juurlink D, et al. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 2006;163:813–821.CrossRefPubMedGoogle Scholar
  21. 21.
    DeBattista C, Schatzberg A. 2003 Psychotropic dosing and monitoring guidelines. Primary Psychiatry 2003;10(7):80–84, 87–96.Google Scholar
  22. 22.
    Culpepper L. Identifying and treating panic disorder in primary care. J Clin Psychiatry 2004;65(suppl 5):1–23.Google Scholar
  23. 23.
    Gliatto M. Generalized anxiety disorder. Am Fam Physician 2000;62(7): 1048–1061.Google Scholar
  24. 24.
    Gale C, Oakley-Bowne M. Generalized anxiety disorder. In: Tovey D, ed. Clinical Evidence, vol. 14. London: BMJ Publishing Group, 2005:334–336.Google Scholar
  25. 25.
    Otto M, Deveney C. Cognitive behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry 2005;66(suppl 4): 28–32.PubMedGoogle Scholar

Copyright information

© Humana Press 2008

Authors and Affiliations

  • James D. Helsley
    • 1
  • Sandra K. Vanin
    • 2
  1. 1.West Virginia University Student Health ServiceMorgantownUSA
  2. 2.West Virginia Bureau of Senior ServicesState Capitol, CharlestonUSA

Personalised recommendations